-
BA’s Focus On Cost Control Notable
Friday, May 21, 2010 - 10:46am | 166Read More...Analysts at Jefferies & Co reiterate their "buy" rating on Boeing (NYSE: BA). The target price for BA is set to $84. BA has the capability to capitalize on opportunity in the forthcoming years. “The Commercial business is experiencing surprisingly strong option exercise rates and appears to be...
-
LOW Q2 Sales Guidance Seems Conservative
Tuesday, May 18, 2010 - 1:42pm | 199Read More...Analysts at Jefferies & Co reiterate their "buy" rating on Lowe's Cos (NYSE: LOW), while raising their estimates for the company. The target price for LOWE is set to $32. LOW has posted better-than-expected Q1 results. According to Jefferies & Co, it seems that Lowe's sales guidance could “...
-
CRM Expected To Post Strong Quarter
Tuesday, May 18, 2010 - 1:38pm | 159Read More...Analysts at Jefferies & Co reiterate their "hold" rating on Salesforce.com (NYSE: CRM), while reducing their estimates for the company. The target price for CRM has been raised from $70 to $80. Jefferies & Co is expecting Salesforce.com to post “another strong quarter given improving demand...
-
Intuit Gets Rating Upgrade (INTU)
Tuesday, May 18, 2010 - 1:34pm | 154Read More...Intuit (NASDAQ: INTU) has been upgraded to “Buy” at Jefferies & Company Inc. The company has also received an EPS estimate boost and price target increase. Intuit (INTU) has strong fundamentals and Jefferies is constructive on the company's future. The shift from aggregate return declines in...
-
Jefferies Boosts Estimates For Boeing (BA)
Tuesday, May 18, 2010 - 12:55pm | 127Read More...Jefferies & Company has maintained its Buy rating on Boeing (NYSE: BA). The company is contemplating raising the 737 rate for Y2012. It has also announced a rate increase to 34 planes per month from the current 31.5 rate. Boeing (BA) is expected to post $3.95 and $5.10 in EPS for year 2010 and...
-
Jefferies Raises Estimates on Eaton Vance (EV)
Tuesday, May 18, 2010 - 9:23am | 155Read More...Jefferies & Company is out with an investor note this morning, raising estimates for Eaton Vance (NYSE: EV); they said that they expect earnings to come in above consensus by $0.02 per hares when the company reports on the 19th. Jeffries analysts cited strong organic growth of its open-ended...
-
Jefferies & Company Trims Estimates On DuPont (DD)
Monday, May 17, 2010 - 2:28pm | 154Read More...In a research report released by Jefferies & Co. today, the firm said that they are lowering 2010 EPS estimates for DuPont (NYSE: DD) $0.10 to $2.55 and 2011 estimates $0.05 to $3.00 to reflect potential F/X and end-market demand headwinds as a result of European volatility. The firm has a...
-
Jefferies Drops Trico Marine (TRMA) Coverage
Monday, May 17, 2010 - 2:21pm | 118Read More...Jefferies & Co. has dropped coverage of Trico Marine Services (NASDAQ: TRMA) as the company has now completed the transition to a subsea services provider. Jefferies wishes to retain its primary focus on OSV, and the offshore and onshore drilling segments. The most recent rating awarded to...
-
Metabolix (MBLX) Price Target Raised
Monday, May 17, 2010 - 2:18pm | 100Read More...Metabolix (NASDAQ: MBLX) has a clear path cut out for itself in the biodegradable plastics business. The commercialization prospects are excellent as current customer interests indicate that expansion plans will be well-received. Food-contact approval has also been obtained, so new avenues will...
-
Jefferies & Company Supermarket Outlook (WMT, KR, SWY)
Monday, May 17, 2010 - 1:08pm | 248Read More...In a research report released today by Jefferies & Co., the firm said that the economy appears to be at an inflection point, where "one road leads to the promised land for the supermarkets of more jobs, additional spending on food-at-home items and inflation. The other road is to the not-so-...
-
Allscripts (MDRX) Upgraded To Buy
Monday, May 17, 2010 - 12:50pm | 108Read More...Analysts at Jefferies & Co. have upgraded Allscripts Healthcare (NASDAQ: MDRX) to Buy from the previous rating of Hold. The price target has also seen an upward revision of $4 to $25. Allscripts is poised to benefit from the push for adoption of electronic health records, as it has already...
-
Jefferies Initiates Greenbrier (GBX) Coverage With A Buy
Monday, May 17, 2010 - 12:38pm | 119Read More...As a reflection of improving trends in the railcar industry, Jefferies & Co. has initiated coverage of Greenbrier Companies (NYSE: GBX) with a buy rating and a price target of $22. This comes shortly after a secondary offering of 4 million shares. Signs are positive for the railcar industry as...
-
Jefferies & Company Healthcare Update (SKH, AMED, GTIV, AFAM, LHCG)
Monday, May 17, 2010 - 12:12pm | 159Read More...Jefferies & Co. cited fears of the European economic fallout for last week's sell off in healthcare stocks and said that valuations in defensive equities like Skilled Healthcare Group (NYSE: SKH), Amedisys (NASDAQ: AMED), and Gentiva Health Services (NASDAQ: GTIV) look "increasingly compelling...
-
Jefferies Bearish On BPZ Resources (BPZ)
Tuesday, May 11, 2010 - 2:31pm | 117Read More...Shares of BPZ Resources (AMEX: BPZ) have been under severe pressure today, falling 12.15% to $5.28. The company reported an EPS loss of $0.02 compared to analysts' estimates of a break-even quarter. Jefferies has an Underperform rating on the stock. BPZ Resources, Inc. (BPZ) is an independent oil...
-
CNQR Exhibits Good Revenue Acceleration, Cash Flows
Wednesday, May 5, 2010 - 1:15pm | 113Read More...Analysts at Jefferies & Co reiterate their "hold" rating on Concur Technologies (NASDAQ: CNQR), while revising their estimates for the company. The target price for CNQR has been raised from $38 to $43. CNQR is seeing sequential revenue acceleration and has raised its FCF guidance despite...

